| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $6.9M | -28.8% |
| SG&A Expense | $8.9M | -14.2% |
| Operating Income | -$23.8M | -19.2% |
| Income Tax | $0 | — |
| Net Income | -$26.9M | -28.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.1M | -64.5% |
| Current Assets | $3.3M | -25.5% |
| Total Assets | $8.5M | -29.8% |
| Current Liabilities | $20.9M | +2.6% |
| Total Liabilities | $21.1M | -0.7% |
| Stockholders' Equity | -$12.6M | -38.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.5M | +8.3% |
| Capital Expenditures | $366K | +77.2% |
| Investing Cash Flow | -$366K | -77.2% |
| Financing Cash Flow | $18.4M | -23.2% |
| Free Cash Flow | -$19.8M | +7.5% |